South Korea Neuroscience Market Size, Share, and COVID-19 Impact Analysis, By Component (Instruments and Consumables), By Technology (Neuro-Microscopy and Brain Imaging), By End-user (Hospitals and Diagnostic Laboratories), and South Korea Neuroscience Market Insights, Industry Trend, Forecasts to 2035

  South Korea Neuroscience Market Insights Forecasts to 2035

• The South Korea Neuroscience Market Size Was Estimated at USD 682.4 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 8.60% from 2025 to 2035
• The South Korea Neuroscience Market Size is Expected to Reach USD 1,691.0 Million by 2035

According to a research report published by Spherical Insights & Consulting, the South Korea Neuroscience Market is anticipated to reach USD 1,691.0 million by 2035, growing at a CAGR of 8.60% from 2025 to 2035. The rising incidence of neurological conditions like epilepsy, brain tumors, Alzheimer's, and traumatic brain traumas. The development of sophisticated technological skills has propelled the advancement of the neuroscience area, and in recent years, the rate at which these R&D capabilities are being created has increased dramatically.

Market Overview

The neuroscience market focuses on the development and commercialization of products and technologies related to the nervous system, including diagnostics, treatments, and research tools for neurological disorders. It improved diagnosis, advanced treatments, and enhanced patient outcomes for conditions like Alzheimer’s, Parkinson’s, and epilepsy. The rising neurological disease prevalence, technological advancements in brain imaging and neurostimulation, and growing investments in research and development. Government is actively supporting this sector through funding initiatives, awareness programs, and regulatory frameworks to accelerate innovation and accessibility. These efforts aim to enhance healthcare infrastructure, promote early diagnosis, and encourage the adoption of neurotechnology, ultimately improving quality of life and reducing the societal burden of neurological diseases.

Report Coverage

This research report categorizes the market for South Korea neuroscience market based on various segments and regions forecasts revenue growth, and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea neuroscience market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea neuroscience market.

Driving Factors

The rising prevalence of neurological disorders due to aging populations and lifestyle changes. Advances in neurotechnology, such as brain imaging, neurostimulation, and AI-powered diagnostics, fuel innovation. Growing awareness about mental health and neurological diseases boosts demand for effective treatments. Additionally, increasing healthcare expenditure and government support for neurological research accelerate market growth.

Restraining Factors

The high costs of advanced diagnostic and treatment technologies limit accessibility in low-income regions. Regulatory challenges and lengthy approval processes slow product launches. A lack of skilled professionals and limited awareness in some areas hinder adoption. Additionally, ethical concerns around neurotechnology and data privacy create barriers. Uncertain reimbursement policies and fragmented healthcare infrastructure in certain markets further restrict growth.

Market Segmentation

The South Korea neuroscience market share is classified into component, technology, and end-user.

• The instruments segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea neuroscience market is segmented by component into instruments and consumables. Among these, the instruments segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. The increasing demand for advanced diagnostic and research tools like imaging devices and electrophysiology equipment. Continuous technological advancements, rising neuroscience research activities, and growing investments in brain disorder diagnostics.

• The neuro-microscopy segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea neuroscience market is segmented by technology into neuro-microscopy and brain imaging. Among these, the neuro-microscopy segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Its critical role in detailed cellular and molecular brain studies. Advances in imaging techniques and increasing neuroscience research investments enhance its precision and application, driving strong demand and a significant CAGR during the forecast period.

• The household segment dominated the share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea neuroscience market is segmented by end-user into hospitals and diagnostic laboratories. Among these, the household segment dominated the share in 2024 and is expected to grow at a significant CAGR during the forecast period. The rising neurological disorder awareness, and the availability of user-friendly diagnostic devices. Convenience, cost-effectiveness, and growing demand for remote monitoring drive its growth, making households a key focus over hospitals and labs in South Korea’s neuroscience market.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea neuroscience market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Recent Developments:

• In January 2024, Neurophet, a Korean startup, developed AI software capable of analyzing and detecting side effects in Alzheimer's disease therapies. Their flagship technologies, Neurophet AQUA and Neurophet SCALE PET, are gaining attention in the digital healthcare sector.

List of Key Companies

• Medtronic Korea
• Abbott Korea
• Stryker Korea
• Neurotech Co., Ltd.
• SolBrain Co., Ltd.
• CureBrain
• Brain4ceuticals
• VUNO
• Lunit
• Seoul Neuroscience Inc.
• iMediSync
• Neuron Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea neuroscience market based on the below-mentioned segments:

 South Korea Neuroscience Market, By Component

• Instruments
• Consumables

South Korea Neuroscience Market, By Technology

• Neuro-Microscopy
• Brain Imaging

South Korea Neuroscience Market, By End Use

• Hospitals
• Diagnostic Laboratories